Productividad Académica Relevante para el Posgrado.

A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study from The Latin American Group of Lymphoproliferative Disorders (GELL)

• Brady E. Beltrán, 1,2 Luis Villela, 3,4 María A. Torres, 5 Victoria Otero, 6 Lorena Fiad, 7 Camila Peña, 8 María E. Cabrera, 8 Pilar León, 8 Henry Idrobo, 9 Denisse A. Castro, 1,2 Sally Paredes, 1 Iván Perdomo, 10 Virginia Abello, 11 Christine Rojas, 12 Ana Ramírez-Ibargüen, 13 Myrna Candelaria, 13 Fernando Pérez-Jacobo, 14 Efrén Montaño-Figueroa, 15 Carlos Best, 16 Andrés Gómez-De León, 17 David Gómez-Almaguer, 17 Guillermo Ruiz-Argüelles, 18 José Hernández-Hernández, 19 Luis Malpica, 20 Eduardo M. Sotomayor, 21 Jorge J. Castillo, 22 on behalf of the The Latin American Group of Lymphoproliferative Disorders (Grupo de Estudio Latinoamericano de Linfoproliferativos [GELL]).
• Clinical Lymphoma, Myeloma & Leukemia, Vol. 20, No. 10, 637-4610.1016/j.clml.2020.04.016

Response to Imatinib Treatment in Chronic Myeloid Leukemia According to BCR-ABL Transcript

• Titania del Carmen Acosta Hernández 1*, Carlos Roberto Best Aguilera 1, Luis Mario Villela Martínez 2, Alicia Elizabeth Guzmán Hernández 1, Arianna Robles Rodríguez 1, Juan Carlos López Hernández 1, Oscar Rodrigo Gómez Vázquez 1, Laura Adriana Rivera Mendoza 1, Bárbara García Reyes 1, Aldo Fernando Adrián Gutiérrez Alatorre 1, Areli Sarai Calderón Valdez 1, Saribethe Mahely Visuetti Pimentel 1.
• Clinical Lymphoma, Myeloma & Leukemia Volume 20, Supplement 1 September 2020 S242

Chronic Myeloid Leukemia: Clinical Prestantation According to Bcr-Abl Transcript Variants

• Titania del Carmen Acosta Hernández 1*, Carlos Roberto Best Aguilera 1,Luis Mario Villela Martínez 2,Alicia Elizabeth Guzmán Hernández 1,Arianna Robles Rodríguez 1,Juan Carlos López Hernández 1,Oscar Rodrigo Gómez Vázquez 1,Laura Adriana Rivera Mendoza 1,Bárbara García Reyes 1,Aldo Fernando Adrián Gutiérrez Alatorre 1,Areli Sarai Calderón Valdez 1,Saribethe Mahely Visuetti Pimentel 1
• Clinical Lymphoma, Myeloma & Leukemia Volume 20 Supplement 1 September 2020 S243

Incidence of Deep Molecular Response and Its Association withClinical and Molecular Variables in Patients with Chronic MyeloidLeukemia Treated with Imatinib in a Population with Limited Health Resources

• Bárbara García Reyes 1*, Carlos Roberto Best Aguilera 1,Carmen Fava 2, Erika Martínez García 3,Andrea Verónica Lujano Benítez 3,Titania del Carmen Acosta Hernández 1,Luis Mario Villela Martínez 4,Alicia Elizabeth Guzmán Hernández 1,Arianna Robles Rodríguez 1,Juan Carlos López Hernández 1,Oscar Rodrigo Gómez Vázquez 1,Laura Adriana Rivera Mendoza 1,Aldo Fernando Adrián Gutiérrez Alatorre 1,Areli Sarai Calderón Valdez 1,Saribethe Mahely Visuetti Pimentel 1
• Clinical Lymphoma, Myeloma & Leukemia Volume 20 Supplement 1 September 2020. S243

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

• Denisse A. Castro, MD, Brady E. Beltrán, MD, Luis Villela M, María Alejandra Torres Viera, MD, Victoria Otero, MD, Lorena Fiad, MD, Camila Peña, MD, Henry Idrobo, MD, Christine Rojas, MD, Iván Perdomo, MD, Pilar León, MD, Karen Lalupu, MD, Sally Rose Paredes, MD, Fernando Pérez-Jacobo, MD, Ana Ramírez -Ibarguen, MD, David Gómez -Almaguer, MD, José A Hernández-Hernández, PhD, Myrna Candelaria, MDPharmD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Andrés Gómez-De León, MD, Efrén Montaño Figueroa, PhD, Melani Otáñez, MD, Carlos Best MD, Luis E Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD
• Blood (2019) 134 (Supplement_1): 4121.DOI: https://doi.org/10.1182/ blood-2019-127479 Published: 2019

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

• Luis Villela M, Ana Ramírez -Ibarguen, MD, Brady E. Beltrán, MD, Victoria Otero, MD, Denisse A. Castro, MD, Myrna Candelaria, MDPharmD, Fernando Pérez-Jacobo, MD, Efrén Montaño Figueroa, PhD, Camila Peña, MD, Sally Rose Paredes, MD, Carlos Best MD, Andrés Gómez-De León, MD, David Gómez -Almaguer, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Henry Idrobo, MD, Virginia Abello, MD, Pilar León, MD, José A Hernández-Hernández, PhD, Yocanxochitl Perfecto, PhD, Melani Otáñez, MD, Sergio Tena, MD, Silvia Rivas-Vera, MD, Luis E Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD
• Blood (2019) 134 (Supplement_1): 1613.DOI: https://doi.org/10.1182/blood-2019-123841 Published: 2019

Ultrasensitive Reactive C.Protein as an affordable biomarker of quantitative expression of the BCR-ABL transcript in Cronic Myeloid Leukemia

• Luis Villela, Melani Otáñez Arce, Carlos Best, Alicia Guzmán, Elva Gabriela Estrada, Laura Rivera Mendoza, Juan Carlos López Hernández, Arianna Robles and David Gómez Almaguer.
• Blood (2018) 132 (Supplement 1): 5450. https://doi.org/10.1182/  Blood-2018-99-119356

Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia philadelphia + (CML-PH+) in accelerated phase (AP), comparison with chronic phase. a long-term retrospective study.

• Rafael Hurtado-Monroy, Berenice Vicente, Diego Sarre-Álvarez, Pablo Vargas-Viveros, Montserrat Rojas, Carlos Best, Judith Cruz-Velazquez, Myrna Candelaria.
• J Clin Oncol 34, 2016 (suppl; abstr e18541) y Clinical Lymphoma, Myeloma & Leukemia September 2016

The age of Mexican patients with Chronic Myeloid Leukemia is quite younger than the reported in USA and European series

• Pablo Vargas-Viveros, M.D.^*,1, Rafael Hurtado Monroy, MD², Eduardo Cervera, MD^*,3, Carlos Best M.D.^*,4, Álvaro Aguayo, M.D.^*,5 and Myrna Candelaria, MD⁶
• Blood 2009, 114: Abstract 4291

Treatment of Acute Myeloid Leukemia with the FLT3 Gene Mutation.

• Carlos Best-Aguilera, O. Rodrigo Gómez-Vázquez, A. Elizabeth Guzmán- Hernández & R. Monserrat Rojas-Sotelo.  
• Curr Oncol Rep 19, 21 (2017). https://doi.org/10.1007/s11912-017-0573-x

Acute leukemia characteristics are different around the world: the Mexican perspective

• Gómez-Almaguer D, Marcos-Ramírez ER, Montaño-Morales EH, Ruiz- Argüelles GJ, Best-Aguilera CR, López-Sánchez M d C, Barrera-Chairez E, López-Arrollo JL, Ramos-Peñafiel CO, León-Peña A, González-López EE, Rivas-García PE, Tellez-Hinojosa CA, Gómez-De León A, Jaime-Pérez JC,
• Clinical Lymphoma, Myeloma and Leukemia (2016), doi: 10.1016/j.clml.2016.09.003.

Placing Ion Channels into a Signaling Network of T Cells: From Maturing Thymocytes to Healthy T Lymphocytes or Leukemic T Lymphoblasts

• Oxana Dobrovinskaya, Iván Delgado-Enciso, Laura Johanna Quintero-Castro, Carlos Best-Aguilera, Rocío Monserrat Rojas-Sotelo, and Igor Pottosin,
• BioMed Research International, Article ID 750203

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

• Experts in Chronic Myeloid Leukemia. 
• Blood, 30 May 2013 volume 121, number 22, 4439-4432

Mexican Guidelines for the Diagnosis and Treatment of Chronic Myeloid Leukaemia

• Eduardo Cervera, Federico Godínez, Rosa Sosa, Ramón Rivas, Carlos Best, Juan Hernández, Adrián Morales, Hugo Zurita, Ivette Carrasco, Jorge Cruz, Álvaro Aguayo, José Espinoza, Juan Labardini, Luis Valero, Judith Cruz, Diana Arcos, Diego Limón, Omar López-Navarro, Daniela Gordillo-Bastidas, Myrna Candelaria, Francisco Torres, Juan Kassack, Oscar de Jesús Pérez Ramírez, Jorge Aquino, Guillermo Díaz, Mariela Cardiel, Margarita Rodríguez, Patricia Montoya, Juan Contreras, María Chávez, Sandra Chávez, David Gómez, Olga Cantú, Jorge Duque, Luis Pita, Eduardo Lobato, Julio López, Antonio López, Pedro González, Jorge Cortés.
• Journal of Cancer Therapy 2013, 747-764 http://dx.doi.org/10.4236/jct.2013.43092 Published Online May 2013 (http://www.scirp.org/journal/jct)

Current Patient Management of Chronic Myeloid Leukemia in Latin America: A Study by the Latin American Leukemia Net (LALNET)

• J. Cortes, MD; 1 C. De Souza, MD;2 M. Ayala, MD;3 I. Bendit, MD;4 C. Best, MD;5 A. Enrico, MD;6 N. Hamerschlak, MD;7 K. Pagnano, MD;8 R. Pasquini, MD;9 L. Meillon, MD10
• Cancer. 2010 Nov 1;116(21):4991-5000.

Tratamiento de la Leucemia Mieloide Crónica (LMC) con Imatinib (IM) en México. Análisis descriptivo.

• Eduardo Cervera, Ramiro Espinoza, Pablo Vargas, Carlos Best, Álvaro Aguayo, Myrna Candelaria, Judith Cruz, Virginia Enríquez, Indira López, Juan Labardini, Rafael Hurtado y Jorge Cortes.
• Gac Méd Méx Vol 145 Supl 1, 2009 p 85-87 

Genotype Ser413/Ser of PAI-2 Polymorphism  Ser413/Cys, is associated with antiphospholipid  syndrome  and  systemic Lupus  erythematosus in  a familial  case. Comparison  with healthy  controls.

• Mónica Vázquez-Del Mercado1*, Teresa Arcelia García-Cobian1, José Francisco Muñoz Valle1, Norma Torres-Carrillo1, Beatriz-Teresita Martín- Márquez1, Víctor Ermilo Arana-Argaez1, Carlos Roberto Best-Aguilera2, Erika-Aurora Martínez García1, Marcelo Heron Petri1, Lourdes Núñez- Atahualpa1, Vidal Delgado-Rizo1,3.
• Scand J Rheumatol. 2007 May-Jun;36(3):206-10

Genotype and Allele Frquency of PAI 1 promoter polymorphism in healthy subjetcts from west of México. Association with Biochemical and Hematological parameters.

• Ruiz Quezada Sandra, Mónica Vázquez del Mercado, Isela Parra Rojas, Héctor Rangel Villalobos, Carlos Best Aguilera, Laura Verónica Sánchez Orozco y José Francisco Muñoz Valle.

• Annales de Génetique 47/2004- 162-165.

Massive myeloid sarcoma affecting the central nervous system, mediastinum, retroperitoneum, liver, and rectum associated with acute myeloblastic leukaemia: a case report

• C R Best-Aguilera, M Vázquez-Del Mercado, J F Muñoz-Valle, L Herrera-Zarate, R E Navarro-Hernández, B T Martin-Márquez, E Oregón-Romero, S Ruiz-Quezada, G M Bonilla, and A Lomelí-Guerrero.

J. Clin. Pathol., Mar 2005; 58: 325 - 3